References
1
Levai A.
Chem. Heterocycl. Compd. (Engl. Transl.)
1997,
33:
647
2
Zvonok AM.
Kuz’menok NM.
Stanishevsky LS.
Khim. Geterotsikl. Soedin.
1990,
5:
633
3
Kuz’menok NM.
Zvonok AM.
Chem. Heterocycl. Compd. (Engl. Transl.)
1996,
3:
324
4a
Lan R.
Liu Q.
Fan P.
Lin S.
Fernando SR.
McCallion DS.
Pertwee R.
Makriyannis A.
J. Med. Chem.
1999,
42:
769
4b
Abadi AH.
Eissa AAH.
Hassan GS.
Chem. Pharm. Bull.
2003,
51:
838
4c
Lange JHM.
Coolen HKAC.
Stuivenberg HH.
Dijksman JAR.
Herremans AHJ.
Ronken E.
Keizer HG.
Tipker K.
McCreary AC.
Veerman W.
Wals HC.
Stork B.
Verveer PC.
Hartog AP.
Jong NMJ.
Adolfs TJP.
Hoogendoorn J.
Kruse CG.
J. Med. Chem.
2004,
47:
627
5
Padwa A.
J. Org. Chem.
1965,
30:
1274
6
Typical Procedure:
Tosylhydrazine (1.02 g, 5.5 mmol) and catalytic amount of the concentrated HCl were added to a solution of 3-aryl-1-(3-phenyloxiran-2-yl)prop-2-en-1-one (1, 5 mmol) in 20 mL THF. The reaction was carried out at r.t. for 12-18 h (control by TLC). After evaporation of the solvent in vacuo the residue was diluted with a mixture of Et2O-benzene (1:3). Further solid pyrazoline 2 was filtered off and purified by recrystallization using EtOH or benzene. The residue mixture was divided on a column and pyrazole 3 and additional pyrazolines 2 were taken.
7 Selected physical and spectroscopic data.
Compound 2a: yield 77%, mp 169-172 °C (EtOH). IR (KBr): νmax = 3504 (OH), 1600 (C=N), 1364, 1168 (S=O), 960 (HC=) cm-1. 1H NMR (400 MHz, CDCl3): δ = 2.39 (3 H, s, CH3), 3.23 (1 H, d, J = 17.6 Hz, CH
2), 3.51 (1 H, d, J = 17.6 Hz, CH
2), 6.63 (1 ,H d, J = 16.4 Hz,
CH=), 7.02 (1 H, d, J = 16.4 Hz, CH
=), 7.23 (2 H, d, J = 8.3 Hz, C6H4), 7.29-7.50 (10 H, m, arom.), 7.69 (2 H, d, J = 8.3 Hz, C6H4). MS: m/z (%) = 418 (5.4) [M+], 91 (100).
Compound 2c: yield 83%, mp 98-100 °C (C6H6). 1H NMR (400 MHz, CDCl3): δ = 2.39 (3 H, s, CH3), 3.21 (1 H, d, J = 17.6 Hz, CH
2), 3.49 (1 H, d, J = 17.6 Hz, CH
2), 6.55 (1 H, d, J = 16.4 Hz, CH
=), 7.00 (1 H, d, J = 16.4 Hz,
CH=), 7.22 (2 H, d, J = 8.3 Hz, C6H4), 7.25 (5 H, m, C6H5), 7.32-7.50 (4 H, m, C6H4), 7.68 (2 H, d, J = 8.3 Hz, C6H4). 13C NMR (125.77 MHz, CDCl3): δ = 21.61 (CH3), 50.50 (CH2), 97.82 (C-OH), 121.91 (CH=), 125.02 (CH=), 125.05, 126.90, 127.96, 128.33, 128.59, 128.94, 129.38, 130.08, 135.15, 137.6, 142.8 (arom.),153.02 (C-3).
Compound 3a: yield 12%, mp 122-124 °C (EtOH). IR (KBr): νmax = 1383, 1176 (S=O), 970 (HC=) cm-1. 1H NMR (400 MHz, CDCl3): δ = 2.37 (3 H, s, CH
3), 6.53 (1 H, s, 4-H), 7.08 (1 H, d, J = 16.6 Hz,
CH=), 7.16 (1 H, d, J = 16.6 Hz, CH
=), 7.20 (2 H, d, J = 8.2 Hz, arom.), 7.27-7.52 (10 H, m, arom.), 7.56 (2 H, d, J = 8.2 Hz, C6H4).
Compound 4i: yield 79%, mp 190-192 °C (MeOH). IR (KBr): νmax = 3385 (NH), 2928, 2856 (CH), 1344, 1160 (S=O) cm-1. 1H NMR (400 MHz, CDCl3): δ = 1.20-2.25 (10 H, m, C6H11), 2.38 (3 H, s, CH3), 2.81 (1 H, m, C6H11), 3.17 (1 H, d, J = 18.0 Hz, CH2), 3.56 (1 H, d, J = 18.0 Hz, CH2), 6.60 (1 H, d, J = 16.4 Hz, CH=), 7.10 (1 H, d, J = 16.4 Hz, CH=), 7.12-7.45 (14 H, m, arom.).
8
Zelenin KN.
Alekseyev VV.
Tygysheva AR.
Yakimovitch SI.
Tetrahedron
1995,
51:
11251
9
Singh SP.
Kumar D.
Jones BG.
Threadgill MD.
J. Fluorine Chem.
1999,
94:
199
10
Zelenin KN.
Tugusheva AR.
Yakimovitch SI.
Alekseyev VV.
Zerova EV.
Chem. Heterocycl. Compd. (Engl. Transl.)
2002,
38:
668
11 Amine (propyl-, cyclohexyl- or benzylamines) (1 mmol) was added to the colorless solution of the pyrazoline 2 (1 mmol) in 10 mL THF or MeOH (the color of the solution becomes brightly orange). Reaction mixture was left at r.t. for 12 h. After evaporation of the solvent in vacuo, the residue was diluted with a mixture of CHCl3-MeOH. Further solid 5-aminopyrazoline 4 was filtered off or taken as an oil.
12
Igidov NM.
Koz’minykh EN.
Kolotova NV.
Koz’minykh VO.
Russ. Chem. Bull.
1999,
7:
1383
13 Pyrazoline 2 (1 mmol) was dissolved in 10 mL THF with catalytic amount of the concentrated HCl and left at 50 °C for 6 h. After solvent evaporation in vacuo, the oil was diluted with Et2O from which pyrazole 3 was crystallized.